Our new Drosophila α-synucleinopathy model was designed using the bipartite QF2 expression system14, rather than the more widely used GAL4/UAS system46, to allow simultaneous and independent manipulation of gene expression in neurons and glia47,48. This evidence concerns the gene LGALS4 and synucleinopathy.